Equities research analysts expect Envista Holdings Corporation (NASDAQ:NVST) to announce sales of $338.74 million for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Envista’s earnings. The highest sales estimate is $386.80 million and the lowest is $310.20 million. The firm is scheduled to announce its next earnings results on Tuesday, August 11th.
According to Zacks, analysts expect that Envista will report full year sales of $2.01 billion for the current fiscal year, with estimates ranging from $1.88 billion to $2.11 billion. For the next financial year, analysts forecast that the firm will post sales of $2.40 billion, with estimates ranging from $2.28 billion to $2.52 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Envista.
Envista (NASDAQ:NVST) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.07). The firm had revenue of $547.20 million for the quarter, compared to the consensus estimate of $569.07 million. The business’s revenue was down 17.1% on a year-over-year basis.
Shares of NVST traded up $0.48 during mid-day trading on Friday, hitting $20.98. The company’s stock had a trading volume of 25,766 shares, compared to its average volume of 3,242,121. The firm has a 50-day moving average price of $19.78 and a 200 day moving average price of $23.05. Envista has a fifty-two week low of $10.08 and a fifty-two week high of $33.30.
A number of institutional investors and hedge funds have recently modified their holdings of NVST. Victory Capital Management Inc. bought a new position in Envista during the fourth quarter valued at approximately $815,000. New York State Common Retirement Fund bought a new position in Envista during the fourth quarter valued at approximately $891,000. Rhumbline Advisers bought a new position in Envista during the fourth quarter valued at approximately $3,754,000. State Street Corp bought a new position in Envista during the fourth quarter valued at approximately $44,878,000. Finally, Sei Investments Co. raised its position in Envista by 198.3% during the fourth quarter. Sei Investments Co. now owns 73,700 shares of the company’s stock valued at $2,194,000 after acquiring an additional 48,996 shares in the last quarter.
Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.
Recommended Story: How to Profit and Limit Losses With Stop Orders
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.